Bagfas Bandirma Gubre Fabrikalari Past Earnings Performance
Past criteria checks 0/6
Bagfas Bandirma Gubre Fabrikalari's earnings have been declining at an average annual rate of -40%, while the Chemicals industry saw earnings growing at 39.4% annually. Revenues have been growing at an average rate of 36.4% per year.
Key information
-40.0%
Earnings growth rate
-30.6%
EPS growth rate
| Chemicals Industry Growth | 50.0% |
| Revenue growth rate | 36.4% |
| Return on equity | -37.5% |
| Net Margin | -82.7% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Bagfas Bandirma Gubre Fabrikalari makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 2,028 | -1,677 | 175 | 0 |
| 31 Dec 23 | 2,882 | -1,507 | 208 | 0 |
| 30 Sep 23 | 3,608 | -697 | 140 | 0 |
| 30 Jun 23 | 4,360 | -277 | 111 | 0 |
| 31 Mar 23 | 4,602 | 188 | 114 | 0 |
| 31 Dec 22 | 3,887 | 1,096 | 69 | 0 |
| 30 Sep 22 | 3,589 | 607 | 65 | 0 |
| 30 Jun 22 | 2,696 | 366 | 62 | 0 |
| 31 Mar 22 | 2,227 | 306 | 53 | 0 |
| 31 Dec 21 | 1,740 | 155 | 44 | 0 |
| 30 Sep 21 | 1,361 | 129 | 38 | 0 |
| 30 Jun 21 | 1,201 | 7 | 35 | 0 |
| 31 Mar 21 | 1,045 | -36 | 32 | 0 |
| 31 Dec 20 | 1,037 | -41 | 32 | 0 |
| 30 Sep 20 | 943 | -121 | 32 | 0 |
| 30 Jun 20 | 957 | 12 | 34 | 0 |
| 31 Mar 20 | 942 | 66 | 37 | 0 |
| 31 Dec 19 | 872 | 82 | 37 | 0 |
| 30 Sep 19 | 743 | 201 | 36 | 0 |
| 30 Jun 19 | 559 | 4 | 33 | 0 |
| 31 Mar 19 | 432 | -84 | 30 | 0 |
| 31 Dec 18 | 357 | -108 | 34 | 0 |
| 30 Sep 18 | 424 | -212 | 36 | 0 |
| 30 Jun 18 | 479 | -85 | 40 | 0 |
| 31 Mar 18 | 483 | -40 | 41 | 0 |
| 31 Dec 17 | 520 | -10 | 40 | 0 |
| 30 Sep 17 | 454 | -56 | 40 | 0 |
| 30 Jun 17 | 439 | -57 | 39 | 0 |
| 31 Mar 17 | 440 | -45 | 39 | 0 |
| 31 Dec 16 | 499 | -38 | 40 | 0 |
| 30 Sep 16 | 533 | 232 | 39 | 0 |
| 30 Jun 16 | 529 | 223 | 36 | 0 |
| 31 Mar 16 | 568 | 233 | 35 | 0 |
| 31 Dec 15 | 461 | 234 | 33 | 0 |
| 30 Sep 15 | 404 | 14 | 32 | 0 |
| 30 Jun 15 | 377 | 34 | 31 | 0 |
| 31 Mar 15 | 343 | 35 | 27 | 0 |
| 31 Dec 14 | 330 | 34 | 28 | 0 |
| 30 Sep 14 | 348 | 25 | 29 | 0 |
| 30 Jun 14 | 359 | 24 | 28 | 0 |
| 31 Mar 14 | 353 | 15 | 27 | 0 |
| 31 Dec 13 | 330 | 2 | 25 | 0 |
Quality Earnings: BAGFS is currently unprofitable.
Growing Profit Margin: BAGFS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BAGFS is unprofitable, and losses have increased over the past 5 years at a rate of 40% per year.
Accelerating Growth: Unable to compare BAGFS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BAGFS is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-3.2%).
Return on Equity
High ROE: BAGFS has a negative Return on Equity (-37.5%), as it is currently unprofitable.